Vivoryon Therapeutics N.V. (0R3M.L)
EUR 1.66
(-2.24%)
EUR 1.66
(-2.24%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -1.12 EUR | 12.5% |
| 2022 | -1.28 EUR | -103.17% |
| 2021 | -0.63 EUR | 24.1% |
| 2020 | -0.83 EUR | -33.87% |
| 2019 | -0.62 EUR | 32.61% |
| 2018 | -0.92 EUR | 4.17% |
| 2017 | -0.96 EUR | 46.37% |
| 2016 | -1.79 EUR | 7.25% |
| 2015 | -1.93 EUR | 17.87% |
| 2014 | -2.35 EUR | -74.07% |
| 2013 | -1.35 EUR | 47.06% |
| 2012 | -2.55 EUR | -14.86% |
| 2011 | -2.22 EUR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -0.52 EUR | 0.0% |
| 2023 Q2 | -0.41 EUR | 0.0% |
| 2023 FY | - EUR | 12.5% |
| 2023 Q4 | -0.72 EUR | 0.0% |
| 2022 FY | - EUR | -103.17% |
| 2022 Q2 | -0.60 EUR | 0.0% |
| 2022 Q4 | -0.68 EUR | 0.0% |
| 2021 Q4 | -0.05 EUR | 0.0% |
| 2021 Q2 | -0.58 EUR | 0.0% |
| 2021 FY | - EUR | 24.1% |
| 2020 FY | - EUR | -33.87% |
| 2020 Q4 | -0.45 EUR | 0.0% |
| 2020 Q2 | -0.38 EUR | 0.0% |
| 2019 Q4 | -0.32 EUR | 0.0% |
| 2019 FY | - EUR | 32.61% |
| 2019 Q2 | -0.30 EUR | 0.0% |
| 2018 Q2 | -0.50 EUR | 0.0% |
| 2018 Q4 | -0.44 EUR | 0.0% |
| 2018 FY | - EUR | 4.17% |
| 2017 Q2 | -0.53 EUR | 0.0% |
| 2017 FY | - EUR | 46.37% |
| 2017 Q4 | -0.45 EUR | 0.0% |
| 2016 FY | - EUR | 7.25% |
| 2016 Q4 | -1.01 EUR | 0.0% |
| 2016 Q2 | -0.81 EUR | 0.0% |
| 2015 FY | - EUR | 17.87% |
| 2015 Q2 | -0.92 EUR | 0.0% |
| 2015 Q4 | -1.04 EUR | 0.0% |
| 2014 Q2 | -0.89 EUR | 0.0% |
| 2014 FY | - EUR | -74.07% |
| 2014 Q4 | -1.40 EUR | 0.0% |
| 2013 Q4 | -1.15 EUR | -238.24% |
| 2013 FY | - EUR | 47.06% |
| 2013 Q3 | -0.34 EUR | 70.18% |
| 2013 Q2 | -1.14 EUR | -235.29% |
| 2013 Q1 | -0.34 EUR | 0.0% |
| 2012 Q1 | -0.39 EUR | 0.0% |
| 2012 Q3 | -0.39 EUR | 0.0% |
| 2012 Q4 | -0.34 EUR | 12.82% |
| 2012 FY | - EUR | -14.86% |
| 2012 Q2 | -0.39 EUR | 0.0% |
| 2011 Q4 | -0.39 EUR | 20.41% |
| 2011 Q1 | -0.49 EUR | 0.0% |
| 2011 Q3 | -0.49 EUR | 0.0% |
| 2011 Q2 | -0.49 EUR | 0.0% |
| 2011 FY | - EUR | 0.0% |
| 2010 Q4 | -0.49 EUR | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Boiron SA | 2.06 EUR | 154.369% |
| Laboratorios Farmaceuticos Rovi, S.A. | 3.20 EUR | 135.0% |
| Vetoquinol SA | 4.70 EUR | 123.83% |
| Valneva SE | -0.73 EUR | -53.425% |
| AB Science S.A. | -0.20 EUR | -460.0% |
| Nanobiotix S.A. | -1.08 EUR | -3.704% |
| PHAXIAM Therapeutics S.A. | -5.00 EUR | 77.6% |
| BioSenic S.A. | -0.21 EUR | -433.333% |
| ABIVAX Société Anonyme | -3.43 EUR | 67.347% |
| Formycon AG | 4.76 EUR | 123.529% |